SSTR2 and neoplasm: Furthermore, SSTR2 gene expression in the ONB tumor samples was considerably higher than that in a cohort of gastrointestinal NET tumor samples, for which the SSTR2-directed radioactive Lutetium (177Lu-DOTATATE) is a U.S. Food and Drug Administration-approved therapy.